Advances in imaging to assess response in rectal cancer -AIR-REC
Research type
Research Study
Full title
Advances in imaging to assess response in rectal cancer-AIR REC
IRAS ID
329328
Contact name
Lynsey Devlin
Contact email
Sponsor organisation
NHS Greater Glasgow and Clyde Research & Innovation
Duration of Study in the UK
1 years, 0 months, 20 days
Research summary
Currently, we do not routinely assess response during radiotherapy treatment for rectal cancer and so patients will have a standard treatment delivered, based on their initial planning scan. Patients are then imaged at follow up
with this imaging being used to assess treatment response and decide on further treatment options. More information i.e. more frequent or detailed imaging, captured during and after treatment could help to improve this decision
making. In this study magnetic resonance (MR) images will be repeated at intervals before and during treatment. This will allow us to evaluate if repeat scanning is
feasible in this patient group. We will also quantify and compare measurements at different treatment timepoints to investigate what they tell us about how the tumour is responding to radiotherapyREC name
East of England - Cambridge Central Research Ethics Committee
REC reference
24/EE/0027
Date of REC Opinion
13 Feb 2024
REC opinion
Further Information Favourable Opinion